Login

David Allmond, CEO, Novacyt 00:00:00

Share On Facebook Share On Twitter

David Allmond: Discussing future infectious disease threats

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Revolutionizing Surgical Technology: A CEO's Perspective on Advancements and Challenges in the Medtech Industry|Anthony Fernando, CEO, Asensus Surgical Inc .
00:10:00
Brian Wesson on Restarting Otso Gold Mine in Finland
00:10:00
Analyzing the Federal Reserve's Landing and Economic Outlook | Scott Sperling, CO-CEO, Thomas H. Lee Partners .
00:10:00
Highcroft Mining: Advancing a World-Class Gold and Silver Project with Strategic Investments and Experienced Leadership
00:10:00
Mark Struthers on NASDAQ’s 'Queue and A' with Tyrone Ross | Thomas Ryan - President and CEO of Sona Wealth
00:10:00
Navigating the Competitive Landscape of Private Equity: Insights from Rich Press
00:10:00
Marvel Gold Corporate Presentation: Mali Gold Exploration
00:10:00
Polymetals Executive Chairman David Sproule Discusses Funding and Offtake Deal for Endeavor Mine | David Sproule, Chairman , Polymetals Resources Ltd.
00:10:00
Kane Brenan Analyzes 2018 Investment Outlook and Its Implications for Major Asset Classes in Insightful Presentation
00:00:00
Forward looking statements about Cyclacel Pharmaceuticals, Inc. - Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, Inc.
00:10:00
Global Market Insights and Investment Strategies with Stephen Gilmore, CIO of New Zealand Super Fund | Capital Allocators Manager Meetings
00:10:00
Four Key Valuation Methods for Private Business Sales

© 2017 - Neuhu+